Does norethindrone (a progestin) increase or decrease Sex Hormone-Binding Globulin (SHBG) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effect of Norethindrone on Sex Hormone-Binding Globulin (SHBG)

Norethindrone decreases SHBG levels, which is opposite to the effect of estrogen-containing contraceptives that typically increase SHBG. 1, 2

Mechanism of Action

Norethindrone, a first-generation progestin, affects SHBG levels through several mechanisms:

  • It has androgenic properties that directly suppress SHBG production in the liver 2
  • When used alone (without estrogen), it decreases SHBG concentrations 1, 3
  • This decrease in SHBG can lead to higher levels of free (unbound) testosterone, despite potentially lowering total testosterone levels 3, 4

Evidence from Clinical Studies

The FDA drug label for norethindrone specifically notes that progestin-only oral contraceptives affect laboratory tests including: "Sex hormone-binding globulin (SHBG) concentrations may be decreased." 1

Research studies confirm this effect:

  • In a 1980 study, women treated with norethindrone enanthate showed SHBG levels that fell within the normal range for men 3
  • A 2001 randomized trial found that continuous combined estradiol and norethindrone acetate increased SHBG levels, but this was due to the estrogen component counteracting the progestin effect 5
  • A 1982 study demonstrated that norethindrone in vaginal rings significantly reduced SHBG binding capacity 4

Comparison with Other Hormonal Contraceptives

The effect of norethindrone on SHBG differs from combined hormonal contraceptives:

  • Combined oral contraceptives (COCs) containing ethinyl estradiol typically increase SHBG levels 2, 6
  • When norethindrone is combined with ethinyl estradiol in COCs, the estrogen effect predominates, resulting in increased SHBG 4
  • A meta-analysis of 42 studies confirmed that all COCs increase SHBG concentrations, though the magnitude varies by estrogen dose and progestin type 6

Clinical Implications

The SHBG-lowering effect of norethindrone has several clinical implications:

  • May benefit women with conditions exacerbated by high SHBG levels
  • Could potentially worsen androgenic symptoms in some women due to increased free testosterone
  • Different from combined hormonal contraceptives that increase SHBG and reduce free testosterone 2
  • This effect contributes to norethindrone's mechanism of action in treating acne, as noted in the JAAD guidelines 2

Monitoring Considerations

When prescribing norethindrone:

  • Be aware that it may alter laboratory test results for SHBG and thyroid binding globulin 1
  • Consider monitoring SHBG levels in patients where androgen status is clinically relevant
  • Remember that the decrease in SHBG may affect the interpretation of total testosterone levels

Important Caveats

  • The magnitude of SHBG reduction may vary between individuals
  • When combined with estrogen (as in combined oral contraceptives), the estrogen effect on SHBG may predominate 4
  • Dose-dependent effects may occur, with higher doses potentially causing greater SHBG suppression
  • Other factors such as weight, thyroid function, and liver health also influence SHBG levels 7

In summary, norethindrone as a progestin-only medication decreases SHBG levels, which is an important consideration when selecting hormonal therapy for patients with specific hormonal needs or concerns.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.